2023-05-03 14:00:53 ET
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)
Q1 2023 Earnings Call
May 03, 2023 , 8:00 a.m. ET
Operator
For further details see:
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript2023-05-03 14:00:53 ET
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)
Q1 2023 Earnings Call
May 03, 2023 , 8:00 a.m. ET
Operator
For further details see:
Amarin Plc (AMRN) Q1 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...